Add to a list

Inactive Instrument

CARMAT Share Price OTC Markets

CKMTF

FR0010907956

Medical Equipment, Supplies & Distribution

OTC Markets Traded

Analysts' recommendations: CARMAT

09/25/09	Carmat: Invest Securities raises target price
11/25/11	Carmat: Invest Securities still a buyer, but cuts TP
04/25/04	Carmat: Invest Securities slightly lowers its target
09/25/09	Carmat: Invest Securities upgrades to buy
09/25/09	Carmat: Oddo BHF reduces its price target

More recommendations

News in other languages: CARMAT

04/03	Carmat, Ynsect… quand les pépites industrielles françaises tombent dans le gouffre de Moore
07/01	Pluxee N : Carmat, Hoffmann, LDC, Pluxee, Technip Energies... les valeurs à suivre aujourd'hui à Paris
07/01	Bourse : GTT et Technip Energy engrangent, Pluxee publie, Carmat disparaît
07/01	CARMAT : A suivre aujourd'hui
07/01	Les records continuent à tomber en bourse

More news

Managers and Directors: CARMAT

Manager	Title	Age	Since
Stéphane Piat CEO	Chief Executive Officer	55	01/09/2016
Pascale d’Arbonneau DFI	Director of Finance/CFO	-	12/12/2018
Christian Latrémouille CTO	Chief Tech/Sci/R&D Officer	-	01/04/2025

Director	Title	Age	Since
Stéphane Piat BRD	Director/Board Member	55	-
Jean-Luc Lemercier BRD	Director/Board Member	68	02/01/2017
Michael Mack BRD	Director/Board Member	79	20/04/2017

More insiders

Carmat SA, formerly known as Carmat SAS is a France-based company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. It specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.

Employees

153

Sector

Medical Equipment, Supplies & Distribution

More about the company

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

Market Cap	61.46L 70.3L 56.48L 52.65L 99.85L 67Cr 1.01Cr 6.78Cr 2.64Cr 33Cr 2.64Cr 2.58Cr 113.38Cr	P/E 2023	-3.09x	P/E 2024	-0.95x
Enterprise Value	5.92Cr 6.78Cr 5.44Cr 5.08Cr 9.63Cr 645.28Cr 9.77Cr 65Cr 25Cr 317.19Cr 25Cr 25Cr 1.09TCr	EV / Sales 2023	56.1x	EV / Sales 2024	13.5x
Free-Float	89.06%	Yield 2023 *	-	Yield 2024	-

07/01	Carmat, Hoffmann, LDC, Pluxee, Technip Energies... Stocks to Watch Today in Paris
07/01	CARMAT: To Watch Today
06/01	Carmat, GTT, Genfit, LDC... Stocks to Watch Tomorrow in Paris
06/01	Carmat Announces Liquidation and Delisting
02/12	Only Takeover Bid for Carmat Approved by Court
02/12	Carmat: Takeover Offer Approved, 88 Jobs Saved	RE
02/12	Carmat receives takeover bid	RE
04/11	Carmat SAS submits bid for Carmat SA within ongoing receivership procedure	RE
15/25/15	CAC 40 Surges on LVMH Results and Easing US-China Tensions
15/25/15	Carmat: Judicial Recovery Continues, New Hearing Set for November 25	RE
15/25/15	Carmat says liquidation review postponed until Nov 25	RE
01/25/01	Carmat: Judicial Liquidation Request to Be Reviewed on October 14	RE
01/25/01	Carmat: Judiciary administrator has submitted request to convert receivership into liquidation to court	RE

02/12	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU
04/11	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU
29/25/29	CARMAT : Inside Information / Other news releases	PU
29/25/29	CARMAT Announces Postponing the Publication of its 2025 Interim Financial Report (Six Months Ended June 30, 2025)	BU
15/25/15	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CARMAT	-50.96%	-54.87%	-	-	70.8L
STRYKER CORPORATION	+4.20%	-1.85%	-17.39%	+9.58%	13TCr
SMITH & NEPHEW PLC	+0.04%	-1.01%	+1.39%	-6.08%	1.28TCr
GLAUKOS CORPORATION	+7.83%	+2.71%	+43.32%	+112.86%	870.84Cr
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+2.29%	+7.17%	-46.92%	-72.29%	406.91Cr
DOUBLE MEDICAL TECHNOLOGY INC.	+4.16%	+8.39%	+25.37%	+43.89%	273.22Cr
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	+2.53%	+23.07%	-7.66%	-13.04%	188.81Cr
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	+3.55%	+8.85%	-0.99%	-23.29%	166.81Cr
L&C BIO CO.,LTD	-5.25%	-5.89%	+179.33%	+133.76%	146.42Cr
Average	-3.51%	+1.23%	+22.06%	+23.17%	1.98TCr
Weighted average by Cap.	+3.90%	+2.90%	-10.46%	+13.01%

	2023	2024
Net sales	38.37L 43.89L 35.26L 32.87L 62.34L 42Cr 63.29L 4.23Cr 1.65Cr 21Cr 1.65Cr 1.61Cr 71Cr	73.44L 84.01L 67.49L 62.91L 1.19Cr 80Cr 1.21Cr 8.1Cr 3.15Cr 39Cr 3.15Cr 3.09Cr 135.49Cr
Net income	-5.39Cr -6.16Cr -4.95Cr -4.61Cr -8.75Cr -586.72Cr -8.89Cr -59Cr -23Cr -288.4Cr -23Cr -23Cr -993.82Cr	-5.14Cr -5.88Cr -4.72Cr -4.4Cr -8.35Cr -559.77Cr -8.48Cr -57Cr -22Cr -275.16Cr -22Cr -22Cr -948.17Cr
Net Debt	4.96Cr 5.68Cr 4.56Cr 4.25Cr 8.06Cr 540.61Cr 8.19Cr 55Cr 21Cr 265.74Cr 21Cr 21Cr 915.72Cr	5.31Cr 6.07Cr 4.88Cr 4.55Cr 8.63Cr 578.34Cr 8.76Cr 59Cr 23Cr 284.29Cr 23Cr 22Cr 979.63Cr

CARMAT Share Price OTC Markets

Stocks

CKMTF

FR0010907956

Medical Equipment, Supplies & Distribution

Valuation: CARMAT

Latest news : CARMAT

Analysts' recommendations: CARMAT

Press Releases: CARMAT

News in other languages: CARMAT

Quotes and Performance

Managers and Directors: CARMAT

Medical Devices & Implants

Financials

Company Profile